Exchange: NYSE Sector: Real Estate Industry: REIT - Healthcare Facilities
-0.23% $47.33
America/New_York / 9 mai 2024 @ 12:21
FUNDAMENTALS | |
---|---|
MarketCap: | 19 158 mill |
EPS: | -0.160 |
P/E: | -295.81 |
Earnings Date: | Aug 01, 2024 |
SharesOutstanding: | 404.77 mill |
Avg Daily Volume: | 2.54 mill |
RATING 2024-05-09 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Sell | |
Return On Asset: | Sell | |
DE: | Buy | |
P/E: | Strong Sell | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -295.81 | sector: PE 30.55 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.69x |
Company: PE -295.81 | industry: PE 431.38 |
DISCOUNTED CASH FLOW VALUE |
---|
$30.73 (-35.08%) $-16.60 |
Date: 2024-05-09 |
Expected Trading Range (DAY) |
---|
$ 46.33 - 48.24 ( +/- 2.02%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-07 | Probst Robert F | Sell | 18 500 | Common Stock |
2024-04-18 | Smith Maurice S | Buy | 42 | Common Stock |
2024-04-18 | Smith Maurice S | Buy | 55 | Common Stock |
2024-04-18 | Shelton James D | Buy | 261 | Common Stock |
2024-04-18 | Roy Sumit | Buy | 42 | Common Stock |
INSIDER POWER |
---|
32.05 |
Last 100 transactions |
Buy: 434 265 | Sell: 218 461 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $47.33 (-0.23% ) |
Volume | 0.412 mill |
Avg. Vol. | 2.54 mill |
% of Avg. Vol | 16.23 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.